Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers

NRG1 rearrangements are oncogenic drivers that are enriched in invasive mucinous adenocarcinomas (IMAs) of the lung. The oncoprotein binds ERBB3-ERBB2 heterodimers and activates downstream signaling, supporting a therapeutic paradigm of ERBB3/ERBB2 inhibition. As proof of concept, a durable response...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Discov
Autors principals: Drilon, Alexander, Somwar, Romel, Mangatt, Biju P., Edgren, Henrik, Desmeules, Patrice, Ruusulehto, Anja, Smith, Roger S., Delasos, Lukas, Vojnic, Morana, Plodkowski, Andrew J., Sabari, Joshua, Ng, Kenneth, Montecalvo, Joseph, Chang, Jason, Tai, Huichun, Lockwood, William W., Martinez, Victor, Riely, Gregory J., Rudin, Charles M., Kris, Mark G., Arcila, Maria E., Matheny, Christopher, Benayed, Ryma, Rekhtman, Natasha, Ladanyi, Marc, Ganji, Gopinath
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5984717/
https://ncbi.nlm.nih.gov/pubmed/29610121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-17-1004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars